Literature DB >> 4109846

Gentamicin and renal failure.

T Kahn, R M Stein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4109846     DOI： 10.1016/s0140-6736(72)90165-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Enzymuria in gentamicin-induced kidney damage.

Authors:  V Patel; F C Luft; M N Yum; B Patel; W Zeman; S A Kleit
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

2.  Nephrotoxicity of cephalosporin-gentamicin combinations in rats.

Authors:  F C Luft; V Patel; M N Yum; S A Kleit
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

3.  Letter: Endotoxic shock complicating transhepatic cholangiography.

Authors:  W I Shedden
Journal:  Br Med J       Date:  1973-09-22

4.  Evidence of gentamicin nephrotoxicity in patients with renal allografts.

Authors:  J M Wellwood; P M Simpson; J R Tighe; A E Thompson
Journal:  Br Med J       Date:  1975-08-02

5.  Gentamicin nephrotoxicity--morphologic and pharmacologic features.

Authors:  W M Bennet; D N Gilbert; D Houghton; G A Porter
Journal:  West J Med       Date:  1977-01

6.  Effect of osmotic diuresis on gentamicin-induced nephrotoxicity in rats.

Authors:  R A Newman; L B Weinstock; D W Gump; M P Hacker; J W Yates
Journal:  Arch Toxicol       Date:  1980-09       Impact factor: 5.153

7.  Amikacin and cephalothin: empiric regimen for granulocytopenic cancer patients.

Authors:  D M Hahn; S C Schimpff; V M Young; C L Fortner; H C Standiford; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

8.  CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms.

Authors:  Wei Bin Fang; Iman Jokar; An Zou; Diana Lambert; Prasanthi Dendukuri; Nikki Cheng
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.